Schlienger, S., Campbell, S., Pasquin, S., Gaboury, L., & Claing, A. (2016). ADP-ribosylation factor 1 expression regulates epithelial-mesenchymal transition and predicts poor clinical outcome in triple-negative breast cancer. Oncotarget.
Chicago ZitierstilSchlienger, Sabrina, Shirley Campbell, Sarah Pasquin, Louis Gaboury, und Audrey Claing. "ADP-ribosylation Factor 1 Expression Regulates Epithelial-mesenchymal Transition and Predicts Poor Clinical Outcome in Triple-negative Breast Cancer." Oncotarget 2016.
MLA ZitierstilSchlienger, Sabrina, et al. "ADP-ribosylation Factor 1 Expression Regulates Epithelial-mesenchymal Transition and Predicts Poor Clinical Outcome in Triple-negative Breast Cancer." Oncotarget 2016.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.